Loading…
Loading…
EQUITY / NASDAQ · XNCM
Zhengye Biotechnology Holding Ltd. Class A Ordinary Shares
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →01/01/2025 – 12/31/2025 · CNY · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗1.16 USD · -2.521%
Observed: Oct 6, 2026, 9:05 AM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
10/05/2026 · 1.19 USD · Volume 14,645
63 actual observations · Latest bar: 2026-10-05 · Market data is indicative; provider terms apply.
3 available financial reports
Research reports →SEC FINANCIAL REPORTS
01/01/2025 – 12/31/2025 · Units
| Metric | 2025 / Year end | 2024 / Year end | Change |
|---|---|---|---|
| Revenue | 116,362,000 CNY | 186,356,000 CNY | -37.56% |
| Operating profit | -70,506,000 CNY | 16,439,000 CNY | -528.89% |
| Net income | -69,784,000 CNY | 11,311,000 CNY | -716.96% |
| Operating cash flow | 13,333,000 CNY | 41,046,000 CNY | -67.52% |
| Total liabilities | 129,757,000 CNY | 140,707,000 CNY | -7.78% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · CNY | 2024 / Year end01/01/2024 – 12/31/2024ConsolidatedUnits · CNY | 2023 / Year end01/01/2023 – 12/31/2023ConsolidatedUnits · CNY |
|---|---|---|---|
| Capital expendituresCash flow statement | 1,008,000 CNY | 13,587,000 CNY | 7,396,000 CNY |
| Financing cash flowCash flow statement | 32,310,000 CNY | -22,129,000 CNY | -18,979,000 CNY |
| Gross profitIncome statement | 23,869,000 CNY | 91,295,000 CNY | 117,508,000 CNY |
| Investing cash flowCash flow statement | -12,630,000 CNY | -27,665,000 CNY | -11,765,000 CNY |
| Net incomeIncome statement | -69,784,000 CNY | 11,311,000 CNY | 31,457,000 CNY |
| Operating cash flowCash flow statement | 13,333,000 CNY | 41,046,000 CNY | 48,184,000 CNY |
| Operating profitIncome statement | -70,506,000 CNY | 16,439,000 CNY | 44,986,000 CNY |
| RevenueIncome statement | 116,362,000 CNY | 186,356,000 CNY | 211,651,000 CNY |
| Total assetsBalance sheet | 436,472,000 CNY | 493,247,000 CNY | — |
| Total equityBalance sheet | 249,848,000 CNY | 283,959,000 CNY | 339,272,000 CNY |
| Total liabilitiesBalance sheet | 129,757,000 CNY | 140,707,000 CNY | — |
| Report source | Open report ↗ Published: 04/28/2026 | Open report ↗ Published: 04/28/2026 | Open report ↗ Published: 04/28/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.